Teva Pharmaceuticals USA Inc recalls Lidocaine 2.5% and Prilocaine 2.5% Cream, USP, packaged in a) 5 g tubes (NDC 0591-2070-72), b) 30 g tubes (NDC 0591-2070-30), Rx…
cGMP Deviations
Read the official notice →- Date
- 2022-05-04
- Country
- United States
- Brand
- Teva Pharmaceuticals
- Product
- Lidocaine 2.5% and Prilocaine 2.5% Cream, USP, packaged in a) 5 g tubes (NDC 0591-2070-72), b) 30 g tubes (NDC 0591-2070-30), Rx Only,…
- Classification
- Class II
- Units
- Nationwide within the United States
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Teva Pharmaceuticals recalls
- 2022-06-29
USTeva Pharmaceuticals USA Inc recalls Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuticals USA Inc., North Wales, PA, 19454, NDC 0555-0808-02.
Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.
- 2022-06-15
- US
Teva Pharmaceuticals USA Inc recalls Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by:…
Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing
FDA · DrugTeva Pharmaceuticals USA IncProduct was distributed nationwide in the US MarketOfficial notice → - 2022-06-08
- US
Teva Pharmaceuticals USA Inc recalls Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North…
Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
- 2022-04-20
- US
Teva Pharmaceuticals USA Inc recalls IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals,…
Presence of Particulate Matter: Product was found to contain silica and iron oxide
- 2022-02-09
- US
- US
Teva Pharmaceuticals USA recalls Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02
Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
Other drugs & medical recalls in the United States
- 2022-05-04
- US
- US
Olympia Compounding Pharmacy dba Olympia Pharmacy recalls NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx…
Failed Reconstitution time
FDA · DrugOlympia Compounding Pharmacy dba Olympia PharmacyDistributed Nationwide in the USAOfficial notice → - US
Olympia Compounding Pharmacy dba Olympia Pharmacy recalls NB-243, Papaverine 30mg/ml . Phentolamine 3mg/ml . Alprostadil 20mcg/ml, 10ml Multi-Dose vials, Rx Only,…
CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
FDA · DrugOlympia Compounding Pharmacy dba Olympia PharmacyDistributed Nationwide in the USAOfficial notice → - US
- US
American Health Packaging recalls Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by:…
Subpotent Drug: Out of specification for assay.
- US
Preferred Pharmaceuticals, Inc. recalls Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
FDA · DrugPreferred Pharmaceuticals, Inc.Nationwide within the U.S to CA, IN and FL.Official notice →